Bill > SB1069

This bill modifies regulations around the sale and purchase of over-the-counter medications containing ephedrine, phenylpropanolamine, or pseudoephedrine, which are commonly used in cold medicines but can also be used to illegally manufacture methamphetamine. The bill establishes strict limits on how much of these drugs an individual can purchase within specific time periods: no more than 7.2 grams in a 30-day period, 3.6 grams in a 24-hour period, and 61.2 grams in a 12-month period. These medications must be sold only from behind a pharmacy counter by a registered pharmacist or pharmacy technician, and no prescription is required for purchases within these limits. Starting October 1, 2026, manufacturers of these drugs will be required to pay monthly fees to a real-time electronic tracking system. The bill also preempts local ordinances that might have stricter regulations and mandates that all sales records be open to law enforcement inspection. Violations of these regulations are classified as a class A misdemeanor, and the bill aims to balance access to legitimate medical treatments with preventing the illegal production of methamphetamine.

Health and Social Services

https://www.senate.mo.gov/26info/BTS_Web/Bill.aspx?SessionType=R&BillID=317